Literature DB >> 12543105

Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.

Zoe McIvor1, Sibyll Hein, Heike Fiegler, Timm Schroeder, Carol Stocking, Ursula Just, Michael Cross.   

Abstract

OBJECTIVES: The Ets-family transcription factor PU.1 is expressed specifically in the hematopoietic system, in which it is absolutely required for the generation of B lymphocytes and macrophages. In contrast, overexpression of PU.1 blocks terminal differentiation of the erythroid lineage, in which it can act as an oncogene. In this study we used a multipotential progenitor cell line to examine the effects of PU.1 overexpression on myeloerythroid commitment within a single model system.
MATERIALS AND METHODS: PU.1 cDNA was introduced transiently and stably into the multipotent, nonleukemic hemopoietic cell line FDCPmix. Transiently transfected cells were isolated by fluorescence-activated cell sorting within 18 hours of transfection. Stable transfectants were selected by antibiotic resistance over a number of weeks. The effects of short- and long-term overexpression of PU.1 on self-renewal, proliferation, and differentiation were investigated.
RESULTS: A transient pulse of expression in multipotent progenitor cells eliminated the options of self-renewal and erythroid differentiation, resulting in commitment to the myeloid lineage. However, this transient pulse of expression did not affect the subsequent lineage choice of bipotent granulocyte/macrophage progenitors. In contrast, continuous expression of PU.1 resulted in a strong bias toward macrophage rather than granulocyte differentiation.
CONCLUSIONS: These results demonstrate promyeloid effects of PU.1 at two distinct stages of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543105     DOI: 10.1016/s0301-472x(02)01017-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

1.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

Authors:  Chanté L Richardson; Lorrie L Delehanty; Grant C Bullock; Claudia M Rival; Kenneth S Tung; Donald L Kimpel; Sara Gardenghi; Stefano Rivella; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

3.  Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis.

Authors:  Linda Yang; Lei Wang; Theodosia A Kalfa; Jose A Cancelas; Xun Shang; Suvarnamala Pushkaran; Jun Mo; David A Williams; Yi Zheng
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

4.  Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling.

Authors:  Krista M Heinonen; Nadia Dubé; Annie Bourdeau; Wayne S Lapp; Michel L Tremblay
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

5.  Isocitrate treatment of acute anemia of inflammation in a mouse model.

Authors:  Airie Kim; Eileen Fung; Sona G Parikh; Victoria Gabayan; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood Cells Mol Dis       Date:  2015-09-28       Impact factor: 3.039

6.  Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.

Authors:  Limengmeng Wang; Haowen Xiao; Xing Zhang; Weichao Liao; Shan Fu; He Huang
Journal:  Int J Oncol       Date:  2015-09-14       Impact factor: 5.650

7.  GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.

Authors:  Pavel Burda; Jarmila Vargova; Nikola Curik; Cyril Salek; Giorgio Lucio Papadopoulos; John Strouboulis; Tomas Stopka
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

Review 8.  PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.

Authors:  Pallavi Gupta; Gangenahalli U Gurudutta; Daman Saluja; Rajendra P Tripathi
Journal:  J Cell Mol Med       Date:  2009-04-06       Impact factor: 5.310

9.  Transcriptional Factor PU.1 Regulates Decidual C1q Expression in Early Pregnancy in Human.

Authors:  Shanmuga Priyaa Madhukaran; Uday Kishore; Kaiser Jamil; Boon Heng Dennis Teo; Mahesh Choolani; Jinhua Lu
Journal:  Front Immunol       Date:  2015-02-16       Impact factor: 7.561

10.  The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.

Authors:  Hiromi Tagoh; Richard Ingram; Nicola Wilson; Giorgia Salvagiotto; Alan J Warren; Deborah Clarke; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.